Luo Y - Search Results

1

A Novel Oncolytic Virus Formulation Based on Mesenchymal Stem Cell-Derived Vesicles for Tumor Therapy.

Zeng F, Huang Y, Xu B, Yao L, Zhang Y, Gao Z, Luo Y. Zeng F, et al. Among authors: luo y. J Cancer. 2025 Jan 1;16(3):700-707. doi: 10.7150/jca.104066. eCollection 2025. J Cancer. 2025. PMID: 39781350 Free PMC article.

2

Mesenchymal Stem Cell Membrane-Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal-Organic Framework Nanoparticles.

Tong Y, Gao M, Luo Y. Tong Y, et al. Among authors: luo y. IET Nanobiotechnol. 2024 Dec 5;2024:1069307. doi: 10.1049/nbt2/1069307. eCollection 2024. IET Nanobiotechnol. 2024. PMID: 39669228 Free PMC article.

3

Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy.

Shen S, Zhang Y, Chen KG, Luo YL, Wang J. Shen S, et al. Among authors: luo yl. Mol Pharm. 2018 Sep 4;15(9):3642-3653. doi: 10.1021/acs.molpharmaceut.7b00997. Epub 2018 Jan 26. Mol Pharm. 2018. PMID: 29337566

4

Photo-Enhanced CRISPR/Cas9 System Enables Robust PD-L1 Gene Disruption in Cancer Cells and Cancer Stem-Like Cells for Efficient Cancer Immunotherapy.

Zhao L, Luo Y, Huang Q, Cao Z, Yang X. Zhao L, et al. Among authors: luo y. Small. 2020 Dec 2:e2004879. doi: 10.1002/smll.202004879. Online ahead of print. Small. 2020. PMID: 33289336

5

Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery.

Cao Z, Li D, Zhao L, Liu M, Ma P, Luo Y, Yang X. Cao Z, et al. Among authors: luo y. Nat Commun. 2022 Apr 19;13(1):2038. doi: 10.1038/s41467-022-29693-8. Nat Commun. 2022. PMID: 35440570 Free PMC article.

6

Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy.

Liu J, Li HJ, Luo YL, Chen YF, Fan YN, Du JZ, Wang J. Liu J, et al. Nano Lett. 2020 Jul 8;20(7):4882-4889. doi: 10.1021/acs.nanolett.0c00893. Epub 2020 Jun 23. Nano Lett. 2020. PMID: 32551705

7

Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection.

Chen YF, Wang Y, Wang Y, Luo YL, Lu ZD, Du XJ, Xu CF, Wang J. Chen YF, et al. Among authors: luo yl. Pharm Res. 2023 Jan;40(1):145-156. doi: 10.1007/s11095-022-03307-w. Epub 2022 Aug 24. Pharm Res. 2023. PMID: 36002611

8

Development of "CLAN" Nanomedicine for Nucleic Acid Therapeutics.

Xu CF, Iqbal S, Shen S, Luo YL, Yang X, Wang J. Xu CF, et al. Small. 2019 Apr;15(16):e1900055. doi: 10.1002/smll.201900055. Epub 2019 Mar 18. Small. 2019. PMID: 30884095 Review.

9

Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles.

Li HJ, Liu J, Luo YL, Chen SB, Liu R, Du JZ, Wang J. Li HJ, et al. Nano Lett. 2019 Dec 11;19(12):8947-8955. doi: 10.1021/acs.nanolett.9b03913. Epub 2019 Nov 11. Nano Lett. 2019. PMID: 31694380

10

Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy.

Liu J, He S, Luo Y, Zhang Y, Du X, Xu C, Pu K, Wang J. Liu J, et al. Among authors: luo y. Adv Mater. 2022 Feb;34(8):e2106654. doi: 10.1002/adma.202106654. Epub 2022 Jan 13. Adv Mater. 2022. PMID: 34854147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,928 results

Search Page

Filters